SERDEXMETHYLPHENIDATE AND DEXMETHYLPHENIDATE

SERDEXMETHYLPHENIDATE AND DEXMETHYLPHENIDATE was reported 741 times

SERDEXMETHYLPHENIDATE AND DEXMETHYLPHENIDATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SEGMENTAL COLITIS ASSOCIATED WITH DIVERTICULOSIS 1 0.2500
1 URINE AMPHETAMINE NEGATIVE 2 0.0741
2 THERAPEUTIC AGENT URINE NEGATIVE 1 0.0400
3 POOR SCHOOL ATTENDANCE 1 0.0400
4 SPECIALIST CONSULTATION 1 0.0357
5 UNHEALTHY DIET 1 0.0200
6 DRUG TITRATION 2 0.0128
7 ALCOHOL TEST FALSE POSITIVE 1 0.0106
8 COMPULSIVE LIP BITING 1 0.0096
9 TOE WALKING 1 0.0085
10 INJECTION SITE MOVEMENT IMPAIRMENT 1 0.0078
11 PENILE DISCOMFORT 1 0.0078
12 CHANGE IN SUSTAINED ATTENTION 2 0.0066
13 FIBROMUSCULAR DYSPLASIA 1 0.0061
14 VITAMIN B12 ABNORMAL 1 0.0051
15 SEVERE CUTANEOUS ADVERSE REACTION 1 0.0042
16 VAGUS NERVE DISORDER 1 0.0040
17 ONYCHOPHAGIA 1 0.0036
18 TONGUE MOVEMENT DISTURBANCE 3 0.0035
19 GENITAL PARAESTHESIA 1 0.0034
20 DERMATILLOMANIA 2 0.0034
21 SPONTANEOUS PENILE ERECTION 2 0.0032
22 STEREOTYPY 3 0.0032
23 TIC 17 0.0031
24 GRANDIOSITY 1 0.0027
25 PATIENT ELOPEMENT 1 0.0027
26 BLUNTED AFFECT 2 0.0027
27 PHYSICAL EXAMINATION ABNORMAL 1 0.0026
28 SUICIDE THREAT 1 0.0026
29 MANUFACTURING MATERIALS ISSUE 1 0.0025
30 VITAMIN D ABNORMAL 1 0.0024
31 DRUG SCREEN NEGATIVE 4 0.0023
32 PRODUCT DOSAGE FORM ISSUE 1 0.0021
33 TONGUE ERUPTION 1 0.0020
34 EXPULSION OF MEDICATION 1 0.0019
35 AUTOSCOPY 1 0.0019
36 THERAPEUTIC RESPONSE SHORTENED 61 0.0018
37 REPETITIVE SPEECH 1 0.0018
38 LACRIMAL DISORDER 1 0.0017
39 NEGATIVE THOUGHTS 5 0.0017
40 ATTENTION DEFICIT HYPERACTIVITY DISORDER 7 0.0017
41 NEUROPSYCHOLOGICAL SYMPTOMS 1 0.0017
42 BACILLUS INFECTION 1 0.0016
43 FEELINGS OF WORTHLESSNESS 2 0.0015
44 ALLERGIC REACTION TO EXCIPIENT 3 0.0015
45 PATIENT-DEVICE INCOMPATIBILITY 1 0.0015
46 PAINFUL ERECTION 1 0.0015
47 GRIMACING 1 0.0013
48 CROUP INFECTIOUS 1 0.0013
49 PARATHYROID DISORDER 1 0.0012
50 DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT 1 0.0012
51 COVID-19 IMMUNISATION 1 0.0012
52 LUNG OPERATION 1 0.0012
53 DRUG DOSE TITRATION NOT PERFORMED 2 0.0011
54 DISTURBANCE IN SEXUAL AROUSAL 1 0.0011
55 DISORGANISED SPEECH 2 0.0011
56 INITIAL INSOMNIA 11 0.0011
57 TONGUE INJURY 1 0.0011
58 SUSPECTED PRODUCT CONTAMINATION 1 0.0010
59 LIBIDO INCREASED 2 0.0010
60 GASTRIC PH DECREASED 1 0.0010
61 SELF-INJURIOUS IDEATION 4 0.0010
62 GASTRIC BYPASS 2 0.0009
63 PHOBIA 1 0.0009
64 CHEMICAL BURN 1 0.0009
65 DISTRACTIBILITY 1 0.0009
66 INTRUSIVE THOUGHTS 1 0.0008
67 PSYCHOMOTOR HYPERACTIVITY 14 0.0008
68 LEARNING DISORDER 2 0.0008
69 SUFFOCATION FEELING 2 0.0008
70 ALLERGY TO CHEMICALS 1 0.0008
71 IMPULSIVE BEHAVIOUR 3 0.0008
72 EMOTIONAL DISORDER 22 0.0007
73 LABELLED DRUG-DRUG INTERACTION ISSUE 1 0.0007
74 GENERALISED ANXIETY DISORDER 1 0.0007
75 EXCESSIVE EYE BLINKING 1 0.0007
76 IMPETIGO 1 0.0007
77 INJECTION SITE PARAESTHESIA 1 0.0007
78 ANGER 22 0.0006
79 DAYDREAMING 1 0.0006
80 IRRITABILITY 38 0.0006
81 EDUCATIONAL PROBLEM 1 0.0006
82 FOOD AVERSION 1 0.0006
83 CHOREA 1 0.0006
84 SERUM FERRITIN DECREASED 1 0.0006
85 TACHYPHRENIA 2 0.0006
86 ALOPECIA AREATA 1 0.0006
87 LOGORRHOEA 2 0.0006
88 PANCREATIC FAILURE 1 0.0006
89 FEAR OF DISEASE 1 0.0006
90 OBSESSIVE THOUGHTS 1 0.0006
91 NASAL OEDEMA 1 0.0006
92 MANIA 9 0.0005
93 SUSPECTED PRODUCT QUALITY ISSUE 1 0.0005
94 OESOPHAGEAL SPASM 1 0.0005
95 BLADDER SPASM 1 0.0005
96 AFFECT LABILITY 5 0.0005
97 DISTURBANCE IN ATTENTION 28 0.0005
98 THERAPEUTIC PRODUCT EFFECT VARIABLE 2 0.0005
99 PRODUCT ADMINISTRATION INTERRUPTED 4 0.0005
100 TONGUE BITING 1 0.0005
101 PSYCHOTIC SYMPTOM 1 0.0005
102 SOCIAL PROBLEM 2 0.0005
103 LIVEDO RETICULARIS 1 0.0005
104 ERECTION INCREASED 2 0.0005
105 SLEEP DEFICIT 1 0.0005
106 FEELING JITTERY 9 0.0005
107 HENOCH-SCHONLEIN PURPURA 1 0.0005
108 THERAPEUTIC PRODUCT EFFECT DELAYED 2 0.0004
109 REACTION TO EXCIPIENT 1 0.0004
110 FORMICATION 3 0.0004
111 ABNORMAL BEHAVIOUR 17 0.0004
112 HALLUCINATION, VISUAL 9 0.0004
113 VOLVULUS 1 0.0004
114 STARING 1 0.0004
115 AGGRESSION 20 0.0004
116 EYELID IRRITATION 1 0.0004
117 PRODUCT PHYSICAL ISSUE 8 0.0004
118 PRODUCT COLOUR ISSUE 2 0.0004
119 DRUG TITRATION ERROR 1 0.0004
120 PANIC ATTACK 14 0.0004
121 HALLUCINATION, AUDITORY 6 0.0004
122 OBSESSIVE-COMPULSIVE DISORDER 3 0.0004
123 LARYNGOSPASM 1 0.0004
124 TRICHORRHEXIS 1 0.0004
125 ELECTRIC SHOCK SENSATION 1 0.0004
126 OXYGEN SATURATION ABNORMAL 1 0.0004
127 PRODUCT AVAILABILITY ISSUE 8 0.0004
128 FINE MOTOR SKILL DYSFUNCTION 1 0.0003
129 ENERGY INCREASED 2 0.0003
130 BRADYKINESIA 2 0.0003
131 TENSION 2 0.0003
132 MOOD SWINGS 10 0.0003
133 PRESCRIBED OVERDOSE 6 0.0003
134 VULVOVAGINAL DRYNESS 1 0.0003
135 PRODUCT PREPARATION ISSUE 2 0.0003
136 ANXIETY DISORDER 1 0.0003
137 PRIAPISM 1 0.0003
138 DROOLING 2 0.0003
139 HYPERREFLEXIA 1 0.0003
140 DEPRESSIVE SYMPTOM 1 0.0003
141 APPENDICECTOMY 1 0.0003
142 TONGUE DISORDER 2 0.0003
143 CRYING 10 0.0003
144 PARADOXICAL DRUG REACTION 1 0.0003
145 BLINDNESS TRANSIENT 2 0.0003
146 ARTHROPOD BITE 2 0.0003
147 AUTOIMMUNE THYROIDITIS 1 0.0003
148 CATHETER SITE INFECTION 1 0.0003
149 PARANASAL SINUS DISCOMFORT 1 0.0003
150 DISSOCIATION 2 0.0003
151 THYROID MASS 1 0.0003
152 AFFECTIVE DISORDER 2 0.0003
153 SUICIDAL IDEATION 23 0.0003
154 ENURESIS 1 0.0002
155 DYSKINESIA 10 0.0002
156 SUICIDAL BEHAVIOUR 1 0.0002
157 SLEEP TERROR 1 0.0002
158 SENSATION OF FOREIGN BODY 2 0.0002
159 SKIN HYPERPIGMENTATION 2 0.0002
160 AGITATION 17 0.0002
161 PRODUCT COMMUNICATION ISSUE 2 0.0002
162 HEART RATE INCREASED 22 0.0002
163 ROSACEA 1 0.0002
164 PERFORMANCE STATUS DECREASED 1 0.0002
165 VIRAL UPPER RESPIRATORY TRACT INFECTION 1 0.0002
166 APATHY 3 0.0002
167 THERAPY CHANGE 2 0.0002
168 HYPERVOLAEMIA 1 0.0002
169 INJECTION SITE INFLAMMATION 1 0.0002
170 HYPOAESTHESIA ORAL 3 0.0002
171 INTENTIONAL SELF-INJURY 4 0.0002
172 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
173 SLUGGISHNESS 2 0.0002
174 PETIT MAL EPILEPSY 1 0.0002
175 ADVERSE EVENT 18 0.0002
176 TRISMUS 1 0.0002
177 TONSILLITIS 1 0.0002
178 BRAIN FOG 3 0.0002
179 PARTIAL SEIZURES 1 0.0002
180 CATATONIA 1 0.0002
181 DEPRESSED MOOD 10 0.0002
182 IMPAIRED WORK ABILITY 4 0.0002
183 BRUXISM 1 0.0002
184 BEHAVIOUR DISORDER 1 0.0002
185 CHEILITIS 1 0.0002
186 MOOD ALTERED 5 0.0002
187 AUTISM SPECTRUM DISORDER 1 0.0002
188 INTESTINAL ISCHAEMIA 1 0.0002
189 CYSTIC FIBROSIS 1 0.0002
190 PERIORBITAL SWELLING 1 0.0002
191 MUSCLE TWITCHING 4 0.0002
192 SKIN WARM 1 0.0002
193 DECREASED INTEREST 1 0.0002
194 MIDDLE INSOMNIA 3 0.0002
195 PRE-EXISTING CONDITION IMPROVED 1 0.0002
196 EPSTEIN-BARR VIRUS INFECTION 1 0.0002
197 BLEPHAROSPASM 1 0.0002
198 SCREAMING 1 0.0002
199 MYDRIASIS 2 0.0002
200 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 11 0.0002
201 INCOHERENT 1 0.0002
202 ANGINA UNSTABLE 1 0.0002
203 ANXIETY 43 0.0002
204 APPETITE DISORDER 1 0.0002
205 PRESCRIBED UNDERDOSE 3 0.0002
206 POST-TRAUMATIC STRESS DISORDER 1 0.0001
207 COLITIS ISCHAEMIC 1 0.0001
208 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 1 0.0001
209 IMPAIRED GASTRIC EMPTYING 2 0.0001
210 INSOMNIA 39 0.0001
211 DECREASED APPETITE 34 0.0001
212 PERIPHERAL COLDNESS 2 0.0001
213 NIGHTMARE 5 0.0001
214 HUNGER 2 0.0001
215 TARDIVE DYSKINESIA 4 0.0001
216 THERMAL BURN 1 0.0001
217 RETCHING 3 0.0001
218 INTENTIONAL DOSE OMISSION 4 0.0001
219 HYPERSOMNIA 4 0.0001
220 POOR QUALITY SLEEP 3 0.0001
221 VISUAL FIELD DEFECT 1 0.0001
222 INTENTIONAL UNDERDOSE 1 0.0001
223 MAJOR DEPRESSION 1 0.0001
224 PSYCHOTIC DISORDER 4 0.0001
225 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
226 FEELING DRUNK 1 0.0001
227 SUNBURN 1 0.0001
228 THERAPEUTIC PRODUCT EFFECT DECREASED 6 0.0001
229 HALLUCINATION 10 0.0001
230 INSURANCE ISSUE 2 0.0001
231 DEVICE PHYSICAL PROPERTY ISSUE 1 0.0001
232 APHTHOUS ULCER 1 0.0001
233 PRODUCT USE COMPLAINT 2 0.0001
234 FRUSTRATION TOLERANCE DECREASED 1 0.0001
235 MUSCLE TIGHTNESS 2 0.0001
236 HICCUPS 1 0.0001
237 FACIAL PARALYSIS 1 0.0001
238 ERECTILE DYSFUNCTION 3 0.0001
239 PRODUCT CONTAINER ISSUE 1 0.0001
240 THERAPEUTIC RESPONSE DECREASED 7 0.0001
241 DEVICE DEFECTIVE 2 0.0001
242 SKIN SWELLING 1 0.0001
243 GRIP STRENGTH DECREASED 1 0.0001
244 EAR INFECTION 3 0.0001
245 THIRST 2 0.0001
246 HEAVY MENSTRUAL BLEEDING 1 0.0001
247 PALPITATIONS 13 0.0001
248 RESTLESS LEGS SYNDROME 2 0.0001
249 RESTLESSNESS 4 0.0001
250 THINKING ABNORMAL 2 0.0001
251 ABDOMINAL PAIN UPPER 22 0.0001
252 DYSTONIA 2 0.0001
253 SKIN FISSURES 2 0.0001
254 PHARYNGEAL SWELLING 1 0.0001
255 HEPATOMEGALY 1 0.0001
256 VITREOUS FLOATERS 1 0.0001
257 TACHYCARDIA 9 0.0001
258 BLADDER DISORDER 1 0.0001
259 INABILITY TO AFFORD MEDICATION 1 0.0001
260 OVARIAN CYST 1 0.0001
261 DRY THROAT 1 0.0001
262 TEMPERATURE INTOLERANCE 1 0.0001
263 TREATMENT FAILURE 8 0.0001
264 PETECHIAE 1 0.0001
265 NERVOUSNESS 5 0.0001
266 WITHDRAWAL SYNDROME 4 0.0001
267 INJECTION SITE DISCOMFORT 1 0.0001
268 SCRATCH 1 0.0001
269 MIGRAINE 9 0.0001
270 HEREDITARY ANGIOEDEMA 1 0.0001
271 PHARYNGITIS STREPTOCOCCAL 1 0.0001
272 DEPRESSION 21 0.0001
273 BIPOLAR DISORDER 1 0.0001
274 PRODUCT PRESCRIBING ISSUE 2 0.0001
275 TREATMENT NONCOMPLIANCE 5 0.0001
276 GASTROINTESTINAL PAIN 1 0.0001
277 FOOT DEFORMITY 1 0.0001
278 OCULAR DISCOMFORT 1 0.0001
279 HEART RATE IRREGULAR 2 0.0001
280 CHOLECYSTECTOMY 1 0.0001
281 SEXUAL DYSFUNCTION 1 0.0001
282 NASAL CONGESTION 5 0.0001
283 SOMNOLENCE 17 0.0001
284 PRODUCT PRESCRIBING ERROR 2 0.0001
285 CHOLECYSTITIS 1 0.0001
286 MUSCLE RIGIDITY 1 0.0001
287 URTICARIA 14 0.0001
288 NOCTURIA 1 0.0001
289 LIVER INJURY 2 0.0001
290 SMALL INTESTINAL OBSTRUCTION 1 0.0001
291 PHARYNGITIS 1 0.0001
292 ILEUS 1 0.0001
293 DERMATITIS ALLERGIC 1 0.0001
294 TREMOR 13 0.0001
295 PRODUCT DOSE OMISSION ISSUE 23 0.0001
296 THERAPY CESSATION 4 0.0001
297 RESPIRATORY TRACT INFECTION 2 0.0001
298 ECZEMA 4 0.0001
299 SPEECH DISORDER 4 0.0001
300 ORAL CANDIDIASIS 1 0.0001
301 IMMUNE SYSTEM DISORDER 1 0.0001
302 QUALITY OF LIFE DECREASED 1 0.0001
303 AKATHISIA 1 0.0001
304 DEVICE MECHANICAL ISSUE 1 0.0001
305 CONTUSION 7 0.0001
306 ANAPHYLACTIC REACTION 4 0.0001
307 FEELING COLD 2 0.0001
308 COORDINATION ABNORMAL 1 0.0001
309 HEADACHE 44 0.0001
310 PARALYSIS 1 0.0001
311 IMPAIRED QUALITY OF LIFE 1 0.0001
312 PARAESTHESIA ORAL 1 0.0001
313 HYPERTHYROIDISM 1 0.0001
314 DRUG INEFFECTIVE 91 0.0001
315 HYPOKINESIA 1 0.0001
316 FLUSHING 7 0.0001
317 FEELING ABNORMAL 16 0.0001
318 LACRIMATION INCREASED 2 0.0001
319 NEPHROLITHIASIS 3 0.0001
320 TENDONITIS 1 0.0001
321 DELUSION 1 0.0001
322 RESPIRATORY TRACT CONGESTION 1 0.0001
323 OBESITY 1 0.0001
324 SEIZURE 7 0.0001
325 LIP SWELLING 2 0.0001
326 ABDOMINAL DISCOMFORT 10 0.0001
327 PERICARDITIS 1 0.0001
328 SCAR 1 0.0001
329 PARANOIA 1 0.0001
330 COLD SWEAT 1 0.0001
331 HEAD DISCOMFORT 1 0.0001
332 THERAPY INTERRUPTED 4 0.0001
333 LEUKOCYTOSIS 1 0.0001
334 TOOTHACHE 1 0.0001
335 HYPERGLYCAEMIA 2 0.0001
336 PHOTOPHOBIA 1 0.0001
337 DYSARTHRIA 2 0.0001
338 SLEEP APNOEA SYNDROME 1 0.0001
339 INCREASED APPETITE 1 0.0001
340 LETHARGY 3 0.0001
341 SEROTONIN SYNDROME 1 0.0001
342 DRUG INTOLERANCE 5 0.0001
343 ERUCTATION 1 0.0001
344 CHOKING 1 0.0001
345 SURGERY 3 0.0001
346 PARAESTHESIA 8 0.0001
347 TASTE DISORDER 1 0.0000
348 PRODUCT PREPARATION ERROR 1 0.0000
349 POLLAKIURIA 2 0.0000
350 DERMATITIS 1 0.0000
351 SKIN EXFOLIATION 4 0.0000
352 VOMITING 22 0.0000
353 PRODUCT DISPENSING ERROR 1 0.0000
354 BLOOD PRESSURE INCREASED 7 0.0000
355 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
356 ANGIOEDEMA 2 0.0000
357 INJECTION SITE PRURITUS 3 0.0000
358 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 9 0.0000
359 CHROMATURIA 1 0.0000
360 MEMORY IMPAIRMENT 6 0.0000
361 SKIN IRRITATION 2 0.0000
362 NAUSEA 34 0.0000
363 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
364 NEURALGIA 1 0.0000
365 INJECTION SITE URTICARIA 1 0.0000
366 EPISTAXIS 3 0.0000
367 HYPOAESTHESIA 6 0.0000
368 UNEVALUABLE EVENT 3 0.0000
369 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
370 ACNE 3 0.0000
371 HYPERHIDROSIS 5 0.0000
372 SKIN ULCER 1 0.0000
373 EXPOSURE VIA SKIN CONTACT 1 0.0000
374 SEDATION 1 0.0000
375 INCORRECT DOSE ADMINISTERED BY DEVICE 1 0.0000
376 ANHEDONIA 1 0.0000
377 HYPERSENSITIVITY 7 0.0000
378 FEAR 1 0.0000
379 PAIN OF SKIN 1 0.0000
380 THROAT TIGHTNESS 1 0.0000
381 RASH 16 0.0000
382 SKIN LESION 1 0.0000
383 ABNORMAL DREAMS 1 0.0000
384 CONDITION AGGRAVATED 11 0.0000
385 MENTAL STATUS CHANGES 1 0.0000
386 WOUND 1 0.0000
387 BLISTER 2 0.0000
388 PRODUCT SUBSTITUTION ISSUE 2 0.0000
389 FATIGUE 27 0.0000
390 DIZZINESS 17 0.0000
391 ERYTHEMA 7 0.0000
392 URINARY INCONTINENCE 1 0.0000
393 APHASIA 1 0.0000
394 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
395 INJECTION SITE RASH 1 0.0000
396 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
397 GYNAECOMASTIA 1 0.0000
398 LIMB DISCOMFORT 1 0.0000
399 WEIGHT DECREASED 9 0.0000
400 SWOLLEN TONGUE 1 0.0000
401 HYPOTHYROIDISM 1 0.0000
402 NIGHT SWEATS 1 0.0000
403 AMNESIA 2 0.0000
404 ALOPECIA 6 0.0000
405 CHOLELITHIASIS 1 0.0000
406 IMPAIRED HEALING 1 0.0000
407 EYE DISORDER 1 0.0000
408 INFUSION RELATED REACTION 2 0.0000
409 VIRAL INFECTION 1 0.0000
410 DEHYDRATION 4 0.0000
411 SKIN DISORDER 1 0.0000
412 URINARY RETENTION 1 0.0000
413 PRODUCT QUALITY ISSUE 4 0.0000
414 CHEST DISCOMFORT 3 0.0000
415 VISION BLURRED 4 0.0000
416 ILLNESS 3 0.0000
417 ABDOMINAL DISTENSION 3 0.0000
418 RASH MACULAR 1 0.0000
419 HEART RATE DECREASED 1 0.0000
420 HYPOXIA 1 0.0000
421 SLEEP DISORDER 2 0.0000
422 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
423 ACCIDENTAL OVERDOSE 1 0.0000
424 DYSURIA 1 0.0000
425 INJECTION SITE MASS 1 0.0000
426 DYSGEUSIA 2 0.0000
427 EYE SWELLING 1 0.0000
428 HOT FLUSH 2 0.0000
429 INTESTINAL OBSTRUCTION 1 0.0000
430 INJECTION SITE SWELLING 2 0.0000
431 PYREXIA 9 0.0000
432 DRUG DOSE OMISSION BY DEVICE 2 0.0000
433 DISORIENTATION 1 0.0000
434 DRUG INTERACTION 4 0.0000
435 INJECTION SITE BRUISING 2 0.0000
436 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
437 RHABDOMYOLYSIS 1 0.0000
438 MYALGIA 4 0.0000
439 PRURITUS 9 0.0000
440 BALANCE DISORDER 2 0.0000
441 DEVICE LEAKAGE 1 0.0000
442 CONSTIPATION 5 0.0000
443 MUSCULOSKELETAL STIFFNESS 2 0.0000
444 COLITIS ULCERATIVE 1 0.0000
445 PULMONARY OEDEMA 1 0.0000
446 DEVICE ISSUE 2 0.0000
447 THROAT IRRITATION 1 0.0000
448 ADVERSE DRUG REACTION 2 0.0000
449 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4 0.0000
450 INCORRECT DOSE ADMINISTERED 5 0.0000
451 TINNITUS 1 0.0000
452 SKIN DISCOLOURATION 1 0.0000
453 NASOPHARYNGITIS 4 0.0000
454 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1 0.0000
455 SWELLING 2 0.0000
456 ARRHYTHMIA 1 0.0000
457 OCULAR HYPERAEMIA 1 0.0000
458 DYSPHAGIA 2 0.0000
459 GAIT DISTURBANCE 4 0.0000
460 INFECTION 3 0.0000
461 HYPOGLYCAEMIA 1 0.0000
462 DYSPEPSIA 2 0.0000
463 FLUID RETENTION 1 0.0000
464 INJECTION SITE PAIN 6 0.0000
465 SINUSITIS 2 0.0000
466 HYPERTENSION 4 0.0000
467 RASH PRURITIC 1 0.0000
468 HAEMATOCHEZIA 1 0.0000
469 ARTHROPATHY 1 0.0000
470 MEDICATION ERROR 1 0.0000
471 PAIN 11 0.0000
472 WEIGHT INCREASED 4 0.0000
473 EYE PAIN 1 0.0000
474 ASTHMA 2 0.0000
475 FLATULENCE 1 0.0000
476 MUSCULAR WEAKNESS 2 0.0000
477 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
478 CHILLS 2 0.0000
479 EMOTIONAL DISTRESS 2 0.0000
480 STOMATITIS 1 0.0000
481 VERTIGO 1 0.0000
482 DISCOMFORT 1 0.0000
483 FEELING HOT 1 0.0000
484 VISUAL IMPAIRMENT 2 0.0000
485 INJECTION SITE ERYTHEMA 2 0.0000
486 EXPOSURE DURING PREGNANCY 1 0.0000
487 MALAISE 7 0.0000
488 INTENTIONAL OVERDOSE 1 0.0000
489 RHINORRHOEA 1 0.0000
490 DEVICE DIFFICULT TO USE 1 0.0000
491 HYPOTENSION 3 0.0000
492 HEPATIC ENZYME INCREASED 1 0.0000
493 INJECTION SITE REACTION 1 0.0000
494 DYSPNOEA 8 0.0000
495 SKIN BURNING SENSATION 1 0.0000
496 RESPIRATORY FAILURE 1 0.0000
497 BRONCHITIS 1 0.0000
498 OFF LABEL USE 11 0.0000
499 DRY MOUTH 1 0.0000
500 DRUG ABUSE 1 0.0000
501 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
502 COVID-19 2 0.0000
503 DIARRHOEA 7 0.0000
504 CHEST PAIN 2 0.0000
505 COUGH 3 0.0000
506 CARDIAC DISORDER 1 0.0000
507 PRODUCT USE ISSUE 2 0.0000
508 ASTHENIA 4 0.0000
509 BLOOD GLUCOSE INCREASED 2 0.0000
510 SYNCOPE 1 0.0000
511 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
512 PNEUMONIA 3 0.0000
513 FALL 3 0.0000
514 INFLUENZA 1 0.0000
515 SEPSIS 1 0.0000
516 RHEUMATOID ARTHRITIS 1 0.0000
517 ABDOMINAL PAIN 2 0.0000
518 LOSS OF CONSCIOUSNESS 1 0.0000
519 DRY SKIN 1 0.0000
520 ARTHRALGIA 3 0.0000
521 PAIN IN EXTREMITY 2 0.0000
522 ACUTE KIDNEY INJURY 1 0.0000
523 PERIPHERAL SWELLING 1 0.0000
524 CONFUSIONAL STATE 1 0.0000
525 URINARY TRACT INFECTION 1 0.0000
526 MUSCLE SPASMS 1 0.0000
527 BACK PAIN 1 0.0000
528 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000